Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Bausch Health Americas, Inc.
With
Progenics Pharmaceuticals, Inc.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Is an adult 18 years of age or older
Has a diagnosis of advanced illness (ie, a terminal illness such as incurable cancer or other end-stage disease)
Has a life expectancy of at least 1 month.
Is receiving opioids on a regular schedule (not just as-needed or rescue doses) for the control of pain or discomfort for at least 2 weeks before the first dose of study drug.
Has constipation that is caused by opioid medications.
You may not be if
Has a known or suspected allergy to methylnaltrexone or other similar compounds (e.g. naltrexone or naloxone).
Has a known or suspected mechanical gastrointestinal obstruction.
Has any potential nonopioid cause of bowel dysfunction that might be a major contributor to the constipation.
Has any other clinically important abnormalities as determined by the investigator that may interfere with his or her participation in or compliance with the study.
Receiving opioid antagonist or partial antagonist products.
Clareo Health | Study Evaluating Subcutaneous Methylnaltrexone For Treatment Of Opioid-Induced Constipation In Patients With Advanced Illness
